CAH241025C115000
- 0.15
- -0.25-62.50%
Cardinal Health Newsroom
Nephron Research Adjusts Price Target on Cardinal Health to $130 From $122
Evercore Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $125
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Cardinal Health (CAH) and Sanofi (OtherSNYNF)
Deutsche Bank Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $119
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $140
TD Cowen Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $116
Evercore Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $125
Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $117
Barclays Reaffirms Their Buy Rating on Cardinal Health (CAH)
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Maintains Target Price $101
Sell Rating on Cardinal Health Amid Acquisition Uncertainty and Competitive Concerns
Cardinal Health Analyst Ratings
Argus Research Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $125
Argus Research Reaffirms Their Buy Rating on Cardinal Health (CAH)
Jefferies Adjusts Price Target on Cardinal Health to $110 From $105
Cardinal Health Analyst Ratings
JPMorgan Adjusts Price Target on Cardinal Health to $123 From $111, Maintains Neutral Rating
Cardinal Health Analyst Ratings
Deutsche Bank Maintains Hold on Cardinal Health, Raises Price Target to $119
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $101 to $137